Norway· NO-ID_71ED1616-B828-4F12-BC76-4D85CE00E0D9

Fumaderm

A fumarsäure-derivate, kombinationen product, registered in Norway by Ukjent (2).

ATC D05BX51

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedFumadermATCD05BX51REGISTER NO.NO-ID_71ED1616-B828-4…PACKS LISTED3CHECKEDOctober 2, 2026

The record

At a glance

FEST (Norway)
Manufacturer
Ukjent (2)
Country
Norway (NO)
ATC code
D05BX51
ATC class
Fumarsäure-Derivate, Kombinationen
Defined daily dose
0.36 g, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
October 2, 2026

Packs & prices · 3

  • no_merkevare_id
    ID_71ED1616-B828-4F12-BC76-4D85CE00E0D9
  • no_varenummer
    229726
    70
  • gtin
    4150007299368

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under D05BX51

Fumarsäure-derivate, kombinationen, as other registers publish it.

All fumarsäure-derivate, kombinationen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/614cdeea-fb27-4dcd-9291-13f084c3d79f
GET /v1/drugs/614cdeea-fb27-4dcd-9291-13f084c3d79f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablett",
  "source": "fest",
  "status": "A",
  "atc_name": "Fumarsyrederivater, kombinasjoner",
  "merkevare_id": "ID_71ED1616-B828-4F12-BC76-4D85CE00E0D9",
  "name_form_strength": "Fumaderm tab",
  "prescription_group": "C"
}

See everything about fumarsäure-derivate, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.